Finance

Lists
CONCORDBIO:NSE
Concord Biotech Ltd
1 341,50 ₹
-0,87%
(-11,80) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CONCORDBIO...
Open
1 362,90 ₹
High
1 366,80 ₹
Low
1 332,00 ₹
Mkt. cap
140,34 մլրդ
Avg. vol.
131,96 հզր
Volume
45,38 հզր
Dividend
0,56%
Quarterly dividend
1,89 ₹
Ex-dividend date
24 հլս, 2026 թ.
P/E ratio
50,99
52-wk high
1 615,00 ₹
52-wk low
987,00 ₹
EPS
26,31 ₹
No. of employees
2 հզր
Open
1 362,90 ₹
High
1 366,80 ₹
Low
1 332,00 ₹
Mkt. cap
140,34 մլրդ
Avg. vol.
131,96 հզր
Volume
45,38 հզր
Dividend
0,56%
Quarterly dividend
1,89 ₹
Ex-dividend date
24 հլս, 2026 թ.
P/E ratio
50,99
52-wk high
1 615,00 ₹
52-wk low
987,00 ₹
EPS
26,31 ₹
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide. It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd
CEO-
Employees1,62 հզր
Founded2000
Headquarters-
Sector-
Last report
03 օգս, 2026 թ.
Fiscal period
Q1 2027
5,52 ₹ / 5,60 ₹
-1,43%miss
Revenue / Est. (INR)
2,57 մլրդ / 2,45 մլրդ
+5,05%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,47 մլրդ
2,78 մլրդ
3,26 մլրդ
2,57 մլրդ
Cost of goods sold
775,44 մլն
941,71 մլն
1,32 մլրդ
890,11 մլն
Cost of revenue
775,44 մլն
941,71 մլն
1,32 մլրդ
890,11 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
444,56 մլն
467,81 մլն
477,71 մլն
436,38 մլն
Operating expense
994,14 մլն
1,03 մլրդ
837,11 մլն
1,04 մլրդ
Total operating expenses
1,77 մլրդ
1,98 մլրդ
2,16 մլրդ
1,93 մլրդ
Operating income
701,00 մլն
802,34 մլն
1,10 մլրդ
642,76 մլն
Other non operating income
133,52 մլն
99,76 մլն
-356,29 մլն
128,26 մլն
EBT including unusual items
856,84 մլն
861,56 մլն
1,14 մլրդ
783,43 մլն
EBT excluding unusual items
856,84 մլն
894,31 մլն
929,35 մլն
783,43 մլն
Income tax expense
226,21 մլն
225,14 մլն
256,08 մլն
206,46 մլն
Effective tax rate
26,40%
26,13%
22,45%
26,35%
Other operating expenses
365,67 մլն
378,34 մլն
163,96 մլն
424,64 մլն
Net income
635,81 մլն
644,77 մլն
887,90 մլն
585,26 մլն
Net profit margin
25,74%
23,21%
27,23%
22,73%
Earnings per share
6,03
6,31
8,46
5,52
Interest and investment income
-
-
24,63 մլն
-
Interest expense
-591,00 հզր
-815,00 հզր
-840,00 հզր
-364,00 հզր
Net interest expenses
-591,00 հզր
-815,00 հզր
23,79 մլն
-364,00 հզր
Depreciation and amortization charges
183,92 մլն
187,47 մլն
195,44 մլն
181,00 մլն
EBITDA
881,84 մլն
933,85 մլն
1,28 մլրդ
824,23 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps